WebQuesto sito è dedicato a tutti coloro che, per un motivo o per l’altro, necessitano di informazioni, consigli e suggerimenti riguardanti le malattie del fegato, le malattie delle vie biliari e quelle del pancreas, in particolare per quelle che possono o devono essere trattate con la chirurgia. Web“Evaluation of serial changes of pancreatic branch duct intraductal papillary mucinous neoplasms by follow-up with magnetic resonance imaging”. Cancer Imaging. vol. 8. 2008. pp. 220-8.
Intraductal papillary mucinous neoplasms - side branch type
WebMay 16, 2024 · Sawai Y, Yamao K, Bhatia V, et al. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy 2010; 42:1077. Oyama H, Tada M, Takagi K, et al. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms. Gastroenterology 2024; 158:226. WebAug 21, 2024 · Side-branch intraductal papillary mucinous neoplasms of the pancreas: outcome of MR imaging surveillance over a 10 years follow-up August 2024 European … csmarich isabelle
(PDF) Follow-up Strategy for IPMN - Academia.edu
WebManagement of Bd-IPMN remains challenging. ... Until we accrue more precise knowledge of the natural history of … Is it safe to follow side branch IPMNs? Adv Surg. 2014;48:13 … Citation, DOI, disclosures and article data. Fukuoka consensus guidelines, also referred to as the Tanaka criteria , is a classification system for intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs) . The prior international consensus guidelines (2006) were referred to as the … See more WebApr 10, 2014 · This distinction is important since observation alone may be appropriate for side-branch IPMN lesions. Side-branch IPMNs can be managed by follow-up, as long as the cyst size is <3 cm and there is no thickened cyst wall, MPD size 5–9 mm, non-enhancing mural nodules, abrupt change in MPD caliber with distal pancreas atrophy, and … csm are checked during the assessment of the: